Jul 6, 2020
Researcher Lends Clinical Expertise to Evaluate New Diagnostic Technologies and Support Science Research Alameda, CA – July 7, 2020 – Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of...
May 11, 2020
Biopharma Leader to Provide Expertise to Develop and Deliver World’s First At-Home Rapid Test for Respiratory Viral Infections Alameda, CA – May 12, 2020 – Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost...
Apr 30, 2020
Alameda, CA – April 30, 2020 – Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, announced today that it has entered into a research collaboration with Janssen...
Feb 20, 2020
We are thrilled to announce today that in February 2020 Alveo Technologies was presented with a Food and Drug Branch License (FDB License) after an in-person inspection by a Food and Drug Investigator from the State of California Food and Drug Branch of the Food and...
Feb 1, 2020
Our company is delighted to announce today, February 1, 2020, that Pooja Goel, Managing Director and Healthcare Practice Lead at Virgo Investment Group, LLC, is joining Alveo’s Scientific Advisory Board. Having held key operational roles responsible for new market and...
May 1, 2019
We are pleased to announce that famed American Geneticist George Church will be joining Alveo’s Scientific Advisory Board. With extensive background in medical diagnostics, including founding application-based companies, George will bring valuable expertise to our...
May 1, 2019
It is my pleasure to announce today, May 1, 2019, that John P. DeVincenzo, M.D. is joining our Scientific Advisory Board. With more than twenty years of pathogenetic and virus research within the healthcare sector, John brings deep experience in pediatric infectious...
Jul 12, 2018
SAN FRANCISCO – July 12, 2018 – Alveo Technologies, Inc., (“Alveo” or “the Company”) a medical diagnostics firm whose mission is to create affordable and accessible infectious disease diagnostics, announced today the appointments of two...
Jan 5, 2018
SAN FRANCISCO – Jan 5, 2018 – Alveo Technologies, Inc., (“Alveo” or “the Company”) whose mission it is to create affordable and accessible infectious disease diagnostic devices, announced the closing of a $38 million Series A financing raised...
error: Content Restricted
